Table of Contents Executive Summary 1 Industry Overview of Kidney Fibrosis Treatment 1.1 Definition of Kidney Fibrosis Treatment 1.2 Kidney Fibrosis Treatment Segment by Type 1.2.1 Global Kidney Fibrosis Treatment Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors 1.2.3 Pirfenidone 1.2.4 Renin Inhibitors 1.2.5 Angiotensin II Receptor Blockers (ARBs) 1.2.6 Vasopeptidase Inhibitors 1.3 Kidney Fibrosis Treatment Segment by Applications 1.3.1 Global Kidney Fibrosis Treatment Consumption Comparison by Applications (2014-2025) 1.3.2 Chronic Kidney Diseases 1.3.3 Kidney Cancer Treatment 1.3.4 Others 1.4 Global Kidney Fibrosis Treatment Overall Market 1.4.1 Global Kidney Fibrosis Treatment Revenue (2014-2025) 1.4.2 Global Kidney Fibrosis Treatment Production (2014-2025) 1.4.3 North America Kidney Fibrosis Treatment Status and Prospect (2014-2025) 1.4.4 Europe Kidney Fibrosis Treatment Status and Prospect (2014-2025) 1.4.5 China Kidney Fibrosis Treatment Status and Prospect (2014-2025) 1.4.6 Japan Kidney Fibrosis Treatment Status and Prospect (2014-2025) 1.4.7 Southeast Asia Kidney Fibrosis Treatment Status and Prospect (2014-2025) 1.4.8 India Kidney Fibrosis Treatment Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Kidney Fibrosis Treatment 2.3 Manufacturing Process Analysis of Kidney Fibrosis Treatment 2.4 Industry Chain Structure of Kidney Fibrosis Treatment 3 Development and Manufacturing Plants Analysis of Kidney Fibrosis Treatment 3.1 Capacity and Commercial Production Date 3.2 Global Kidney Fibrosis Treatment Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Kidney Fibrosis Treatment 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Kidney Fibrosis Treatment Production and Capacity Analysis 4.2 Kidney Fibrosis Treatment Revenue Analysis 4.3 Kidney Fibrosis Treatment Price Analysis 4.4 Market Concentration Degree 5 Kidney Fibrosis Treatment Regional Market Analysis 5.1 Kidney Fibrosis Treatment Production by Regions 5.1.1 Global Kidney Fibrosis Treatment Production by Regions 5.1.2 Global Kidney Fibrosis Treatment Revenue by Regions 5.2 Kidney Fibrosis Treatment Consumption by Regions 5.3 North America Kidney Fibrosis Treatment Market Analysis 5.3.1 North America Kidney Fibrosis Treatment Production 5.3.2 North America Kidney Fibrosis Treatment Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Kidney Fibrosis Treatment Import and Export 5.4 Europe Kidney Fibrosis Treatment Market Analysis 5.4.1 Europe Kidney Fibrosis Treatment Production 5.4.2 Europe Kidney Fibrosis Treatment Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Kidney Fibrosis Treatment Import and Export 5.5 China Kidney Fibrosis Treatment Market Analysis 5.5.1 China Kidney Fibrosis Treatment Production 5.5.2 China Kidney Fibrosis Treatment Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Kidney Fibrosis Treatment Import and Export 5.6 Japan Kidney Fibrosis Treatment Market Analysis 5.6.1 Japan Kidney Fibrosis Treatment Production 5.6.2 Japan Kidney Fibrosis Treatment Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Kidney Fibrosis Treatment Import and Export 5.7 Southeast Asia Kidney Fibrosis Treatment Market Analysis 5.7.1 Southeast Asia Kidney Fibrosis Treatment Production 5.7.2 Southeast Asia Kidney Fibrosis Treatment Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Kidney Fibrosis Treatment Import and Export 5.8 India Kidney Fibrosis Treatment Market Analysis 5.8.1 India Kidney Fibrosis Treatment Production 5.8.2 India Kidney Fibrosis Treatment Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Kidney Fibrosis Treatment Import and Export 6 Kidney Fibrosis Treatment Segment Market Analysis (by Type) 6.1 Global Kidney Fibrosis Treatment Production by Type 6.2 Global Kidney Fibrosis Treatment Revenue by Type 6.3 Kidney Fibrosis Treatment Price by Type 7 Kidney Fibrosis Treatment Segment Market Analysis (by Application) 7.1 Global Kidney Fibrosis Treatment Consumption by Application 7.2 Global Kidney Fibrosis Treatment Consumption Market Share by Application (2014-2019) 8 Kidney Fibrosis Treatment Major Manufacturers Analysis 8.1 Merck & Co(US) 8.1.1 Merck & Co(US) Kidney Fibrosis Treatment Production Sites and Area Served 8.1.2 Merck & Co(US) Product Introduction, Application and Specification 8.1.3 Merck & Co(US) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Pfizer Inc(US) 8.2.1 Pfizer Inc(US) Kidney Fibrosis Treatment Production Sites and Area Served 8.2.2 Pfizer Inc(US) Product Introduction, Application and Specification 8.2.3 Pfizer Inc(US) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 F. Hoffman-La Roche(Switzerland) 8.3.1 F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Production Sites and Area Served 8.3.2 F. Hoffman-La Roche(Switzerland) Product Introduction, Application and Specification 8.3.3 F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 InterMune Inc(US) 8.4.1 InterMune Inc(US) Kidney Fibrosis Treatment Production Sites and Area Served 8.4.2 InterMune Inc(US) Product Introduction, Application and Specification 8.4.3 InterMune Inc(US) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Galectin Therapeutics(US) 8.5.1 Galectin Therapeutics(US) Kidney Fibrosis Treatment Production Sites and Area Served 8.5.2 Galectin Therapeutics(US) Product Introduction, Application and Specification 8.5.3 Galectin Therapeutics(US) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 La Jolla Pharmaceutical Company(US) 8.6.1 La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Production Sites and Area Served 8.6.2 La Jolla Pharmaceutical Company(US) Product Introduction, Application and Specification 8.6.3 La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 ProMetic Life-Sciences Inc(Canada) 8.7.1 ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Production Sites and Area Served 8.7.2 ProMetic Life-Sciences Inc(Canada) Product Introduction, Application and Specification 8.7.3 ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 BioLine Rx(Israel) 8.8.1 BioLine Rx(Israel) Kidney Fibrosis Treatment Production Sites and Area Served 8.8.2 BioLine Rx(Israel) Product Introduction, Application and Specification 8.8.3 BioLine Rx(Israel) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Genzyme Corporation(US) 8.9.1 Genzyme Corporation(US) Kidney Fibrosis Treatment Production Sites and Area Served 8.9.2 Genzyme Corporation(US) Product Introduction, Application and Specification 8.9.3 Genzyme Corporation(US) Kidney Fibrosis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 9 Development Trend of Analysis of Kidney Fibrosis Treatment Market 9.1 Global Kidney Fibrosis Treatment Market Trend Analysis 9.1.1 Global Kidney Fibrosis Treatment Market Size (Volume and Value) Forecast 2019-2025 9.2 Kidney Fibrosis Treatment Regional Market Trend 9.2.1 North America Kidney Fibrosis Treatment Forecast 2019-2025 9.2.2 Europe Kidney Fibrosis Treatment Forecast 2019-2025 9.2.3 China Kidney Fibrosis Treatment Forecast 2019-2025 9.2.4 Japan Kidney Fibrosis Treatment Forecast 2019-2025 9.2.5 Southeast Asia Kidney Fibrosis Treatment Forecast 2019-2025 9.2.6 India Kidney Fibrosis Treatment Forecast 2019-2025 9.3 Kidney Fibrosis Treatment Market Trend (Product Type) 9.4 Kidney Fibrosis Treatment Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Kidney Fibrosis Treatment Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Kidney Fibrosis Treatment Table Global Kidney Fibrosis Treatment Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Kidney Fibrosis Treatment Production Market Share by Types in 2018 Figure Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture Figure Pirfenidone Product Picture Figure Renin Inhibitors Product Picture Figure Angiotensin II Receptor Blockers (ARBs) Product Picture Figure Vasopeptidase Inhibitors Product Picture Table Global Kidney Fibrosis Treatment Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Kidney Fibrosis Treatment Consumption Market Share by Applications in 2018 Figure Chronic Kidney Diseases Figure Kidney Cancer Treatment Figure Others Figure Global Kidney Fibrosis Treatment Revenue (Million USD) (2014-2025) Figure Global Kidney Fibrosis Treatment Production (K Units) (2014-2025) Figure North America Kidney Fibrosis Treatment Market Size (Million USD) (2014-2025) Figure Europe Kidney Fibrosis Treatment Market Size (Million USD) (2014-2025) Figure China Kidney Fibrosis Treatment Market Size (Million USD) (2014-2025) Figure Japan Kidney Fibrosis Treatment Market Size (Million USD) (2014-2025) Figure Southeast Asia Kidney Fibrosis Treatment Market Size (Million USD) (2014-2025) Figure India Kidney Fibrosis Treatment Market Size (Million USD) (2014-2025) Table Kidney Fibrosis Treatment Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Kidney Fibrosis Treatment in 2018 Figure Manufacturing Process Analysis of Kidney Fibrosis Treatment Figure Industry Chain Structure of Kidney Fibrosis Treatment Table Capacity and Commercial Production Date of Key Manufacturers Table Global Kidney Fibrosis Treatment Manufacturing Plants Distribution Table Kidney Fibrosis Treatment Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Kidney Fibrosis Treatment Capacity (K Units) of Major Manufacturers (2014-2019) Table Kidney Fibrosis Treatment Production (K Units) of Major Manufacturers (2014-2019) Table Kidney Fibrosis Treatment Production Market Share of Major Manufacturers (2014-2019) Figure Kidney Fibrosis Treatment Production Share by Manufacturers in 2018 Table Kidney Fibrosis Treatment Revenue (Million US$) of Major Manufacturers (2014-2019) Table Kidney Fibrosis Treatment Revenue Market Share of Major Manufacturers (2014-2019) Figure Kidney Fibrosis Treatment Revenue Share by Manufacturers in 2018 Table Kidney Fibrosis Treatment Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Kidney Fibrosis Treatment Production by Regions 2014-2019 (K Units) Table Global Kidney Fibrosis Treatment Production Market Share by Regions 2014-2019 Figure Global Kidney Fibrosis Treatment Production Market Share by Regions in 2018 Table Global Kidney Fibrosis Treatment Revenue by Regions 2014-2019 (Million USD) Table Global Kidney Fibrosis Treatment Revenue Market Share by Regions 2014-2019 Figure Global Kidney Fibrosis Treatment Revenue Market Share by Regions in 2018 Table Global Kidney Fibrosis Treatment Consumption by Regions 2014-2019 (K Units) Table Global Kidney Fibrosis Treatment Consumption Market Share by Regions 2014-2019 Figure North America Kidney Fibrosis Treatment Production Growth Rate 2014-2019 (K Units) Figure North America Kidney Fibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD) Table North America Kidney Fibrosis Treatment Production, Consumption Import and Export (K Units) Figure Europe Kidney Fibrosis Treatment Production Growth Rate 2014-2019 (K Units) Figure Europe Kidney Fibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Europe Kidney Fibrosis Treatment Production, Consumption Import and Export (K Units) Figure China Kidney Fibrosis Treatment Production Growth Rate 2014-2019 (K Units) Figure China Kidney Fibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD) Table China Kidney Fibrosis Treatment Production, Consumption Import and Export (K Units) Figure Japan Kidney Fibrosis Treatment Production Growth Rate 2014-2019 (K Units) Figure Japan Kidney Fibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Japan Kidney Fibrosis Treatment Production, Consumption Import and Export (K Units) Figure Southeast Asia Kidney Fibrosis Treatment Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Kidney Fibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Kidney Fibrosis Treatment Production, Consumption Import and Export (K Units) Figure India Kidney Fibrosis Treatment Production Growth Rate 2014-2019 (K Units) Figure India Kidney Fibrosis Treatment Revenue Growth Rate 2014-2019 (Million USD) Table India Kidney Fibrosis Treatment Production, Consumption Import and Export (K Units) Figure Global Consumption Kidney Fibrosis Treatment Market Share by Application (2014-2019) Figure Global Value (Consumption) Kidney Fibrosis Treatment Market Share by Application (2014-2019) Table Merck & Co(US) Kidney Fibrosis Treatment Production Sites and Area Served Table Merck & Co(US) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table Merck & Co(US) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck & Co(US) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table Merck & Co(US) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure Merck & Co(US) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table Merck & Co(US) Kidney Fibrosis Treatment Main Business and Markets Served Table Pfizer Inc(US) Kidney Fibrosis Treatment Production Sites and Area Served Table Pfizer Inc(US) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table Pfizer Inc(US) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Inc(US) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table Pfizer Inc(US) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure Pfizer Inc(US) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table Pfizer Inc(US) Kidney Fibrosis Treatment Main Business and Markets Served Table F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Production Sites and Area Served Table F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Main Business and Markets Served Table InterMune Inc(US) Kidney Fibrosis Treatment Production Sites and Area Served Table InterMune Inc(US) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table InterMune Inc(US) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table InterMune Inc(US) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table InterMune Inc(US) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure InterMune Inc(US) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table InterMune Inc(US) Kidney Fibrosis Treatment Main Business and Markets Served Table Galectin Therapeutics(US) Kidney Fibrosis Treatment Production Sites and Area Served Table Galectin Therapeutics(US) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table Galectin Therapeutics(US) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Galectin Therapeutics(US) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table Galectin Therapeutics(US) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure Galectin Therapeutics(US) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table Galectin Therapeutics(US) Kidney Fibrosis Treatment Main Business and Markets Served Table La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Production Sites and Area Served Table La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Main Business and Markets Served Table ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Production Sites and Area Served Table ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Main Business and Markets Served Table BioLine Rx(Israel) Kidney Fibrosis Treatment Production Sites and Area Served Table BioLine Rx(Israel) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table BioLine Rx(Israel) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table BioLine Rx(Israel) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table BioLine Rx(Israel) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure BioLine Rx(Israel) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table BioLine Rx(Israel) Kidney Fibrosis Treatment Main Business and Markets Served Table Genzyme Corporation(US) Kidney Fibrosis Treatment Production Sites and Area Served Table Genzyme Corporation(US) Kidney Fibrosis Treatment Product Introduction, Application and Specification Table Genzyme Corporation(US) Kidney Fibrosis Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Genzyme Corporation(US) Kidney Fibrosis Treatment Production Growth Rate (2014-2019) Table Genzyme Corporation(US) Kidney Fibrosis Treatment Production Market Share (2014-2019) Figure Genzyme Corporation(US) Kidney Fibrosis Treatment Revenue Market Share (2014-2019) Table Genzyme Corporation(US) Kidney Fibrosis Treatment Main Business and Markets Served Figure Global Kidney Fibrosis Treatment Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Kidney Fibrosis Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Kidney Fibrosis Treatment Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Kidney Fibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Kidney Fibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Kidney Fibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Kidney Fibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Kidney Fibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure China Kidney Fibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Kidney Fibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Kidney Fibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Kidney Fibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Kidney Fibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Kidney Fibrosis Treatment Production Growth Rate Forecast 2019-2025 (K Units) Figure India Kidney Fibrosis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Kidney Fibrosis Treatment by Type (2019-2025) Table Global Consumption (K Units) of Kidney Fibrosis Treatment by Application (2019-2025) Table Kidney Fibrosis Treatment Distributors List Table Kidney Fibrosis Treatment Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Merck & Co(US) Pfizer Inc(US) F. Hoffman-La Roche(Switzerland) InterMune Inc(US) Galectin Therapeutics(US) La Jolla Pharmaceutical Company(US) ProMetic Life-Sciences Inc(Canada) BioLine Rx(Israel) Genzyme Corporation(US)